The  logo

Should pharmacists be allowed to substitute generics for prescribed brands?

Vote

Please login or register to vote
Yes (please add a comment)
63% (44 votes)
No (please add a comment)
7% (5 votes)
Sometimes (please explain)
30% (21 votes)
Total votes: 70

No to generic substitution

Unless and until generic manufacturers improve the quality of their packaging;ie making pack design distinct for different stregnths of medicine then opportunity of confusion for the patient will remain, not to say picking errors in the pharmacy. Leave the situation as it is. regards BobDunkley

substituting generics for prescribed brands

In my opinion pharmacist should be allowed to exercise and apply their professional knowledge in substituting generics for branded medications, especailly for drugs in which there is no pharmacokinetics difference between branded and generics.

generic substitution

the budgets in health care are not infinate. by allowong substitution money can be saved and used for newer drugs that have no generic. This would allow PCT's to sanction newer drug use (they would have more money) and bring the NHS up to date. perhaps dispense has in the US. offer the patient the branded or the generic at all dispensing times. if they want the generic they get it via the NHS "free". if they insist on the branded they must pay the difference in price, with no exceptions. e.g. simvastatin at £1 per pack (free if they will have it) or zocor at £20 per pack the must pay, at the time of dispensing £19. with no exceptions. this could be irrespective of what is on the RX. it allows patients to excercise their choice it is not a tax on the poor or ill. also as in the US nearly all go with the generic "free" drug. funny that, but of course because the NHS is free at the source to most, patients put no value on what they are getting and take them anyway. just look at any pharmacy "to be collected" shelves and the dates on the RX's. they are usually old (>1 month) and not collected. the patients have not forgotton, they did'ent need them or were not taking them (MUR time)and have wasted the Dr time, the pharmacy time and the cost of the drug. but to a patient that does not matter, it's free and they can always order more for free when they really need them. I would bet that the US system means that there is no stock piling and that patients only get thier meds when they need them and has cheap as possible i.e. stuff the branded. why pay $19 for something that is $1 and even this $1 can be claimed on their health insurance-so it's free. take the branded and thier health insurance will refund them $1 and the patient is out $19. hence the reason they nearly always take the generic. a goog system for the UK providing the money saved is put back into the drug budget global sum and not used for other reasons. jb

Generic substitution

My answer is given as a user of medication rather than as a provider. the variability of generic medication is such that I will accept certain generic products from certain manufacturers and refuse others. the variability in efficacy is such that my rejection is based on good, albeit personal, evidence. I am, however, in a priveliged position in that I can ask my dispensing pharmacist to provide generic brands with which I am content and in the case of one item reject generics altogether, luckily there is very little difference in DT price of this item and the proprietory. Patients in general are not able to dictate/request brands, whether generic or not, and many pharmacists are unsympathetic to their views and dispense the cheapest available. This position is a disgrace and generic substitution will, if allowed, re-inforce their position. That said I am in favour of GS only where a branded product is genuinely unavailable and the patient need immediate provision. Perhaps this will force the industry to reject its current quota system. I am not aware that a quota system was implemented in Europe when the UK was parallel importing rather than exporting, and am happy to be corrected if wrong. I regret that I must take a position which protects the public from the, hopefully few - but probably not, pharmacists who may exploit the possibility of GS for nothing more than personal gain.

Generic substitution

Patients should have the option to pay extra for a branded drug, or particular generic brand, if they so wish. Similarly, I, as a pharmacist should have the option to over-ride the prescriber's choice of brand, with the patient's agreement, if it allows a more rapid supply, as happens with some dispensing practices who appear to have formulary policies to prescribe certain branded drugs (especially those which are priced at or under Drug tariff prices) rather than the generic equivalent.

Generic substitution

I am generally in favour of GS for those clinical areas where we have good evidence for no discernible differences between effect. I agree that the principles of top-ups need to be allowed for brand supply so that we can supply the brand to the patient at no financial loss, although how this would be applied fairly across different contractors could cause problems. My biggest fear is that the principles of GS will cause prescribing advisors, PCT budget holders etc. to take a closer look at cat M pricing for items where the brand is cheaper and the resultant push cut money from the drug budgets further. Our clamour to get GS in place may backfire on us. Beware.

Substituting generics for branded products

I consider that the issue is not as simple as it appears. Some drugs need to be prescribed by brand because of differences in bio-availability etc having an effect on efficacy and these need to be excluded. Substitution of the majority of products would not be problematic but community pharmacies may use financial considerations to decide whether a brand or a generic is used. Because patients don't always recognise that a branded product is equivalent to a product with a generic name this could lead to confusion of identity. Hospitals switch scripts to the product they have in the formulary (often a brand and not a generic!) but with this they have agreement with a discrete cohort of prescribers. I think that it needs to be fully thought through before any consideration of implementation.

Generic substitution

I feel that on occassions it is appropaite to allow generic substitution and this will help minimise NHS medication cost expenditure and ensure patients receive their medication in a timely manner but preventing delays on ordering special brands from manufacturers and accounting for menufacturer supply issues. However it does need to be considered that soem medications are brand specific and therefore generic substitution should only be at the pharmacists discreetion. Patient compliance is also a concern as some patients will only take specific brands or the colour tablet/capsule etc that they recognise. Therefore whenever a medication is substituted the pharmacist needs to ensure the patient appreciates that the exact same active ingredient is being supplied. To finish I am a hospital pharmacist and generic substitution is common practice in hospitals and occurs with minimal problems. I see no reason why it cannot happen in community, for the benefit of all, if caution is used.